86 related articles for article (PubMed ID: 9170923)
1. [Molecular mechanisms of allergy].
Totsuka M; Kaminogawa S
Tanpakushitsu Kakusan Koso; 1997 May; 42(7 Suppl):1055-62. PubMed ID: 9170923
[No Abstract] [Full Text] [Related]
2. Mechanisms of IgE-mediated allergic reactions.
Bloebaum RM; Dharajiya N; Grant JA
Clin Allergy Immunol; 2004; 18():65-84. PubMed ID: 15042909
[No Abstract] [Full Text] [Related]
3. Exposing the mast cell: its novel integrated role in allergy.
Polosa R; Crimi N
Ann Ital Med Int; 1998; 13(2):78-80. PubMed ID: 9734139
[TBL] [Abstract][Full Text] [Related]
4. Protein and cell engineering of components of the human immunoglobulin E receptor/effector system: applications for therapy and diagnosis.
Helm BA; Sayers I; Swan J; Smyth LJ; Cain SA; Suter M; Machado DC; Spivey AC; Padlan EA
Technol Health Care; 1998 Sep; 6(2-3):195-207. PubMed ID: 9839864
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of reagin antibodies (IgE) in helminthic allergy].
Ershov VS
Veterinariia; 1975 Nov; (11):51-5. PubMed ID: 766362
[No Abstract] [Full Text] [Related]
6. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
[TBL] [Abstract][Full Text] [Related]
7. The question of atopy (genetics and immunological mechanisms in immediate hypersensitivity).
Carini C; Brostoff J
Ric Clin Lab; 1982; 12(2):371-91. PubMed ID: 6981185
[No Abstract] [Full Text] [Related]
8. [Strategy for allergy treatment with IgE-Fc epsilon RI-mast cell axis as the target].
Ra T
Arerugi; 1998 Apr; 47(4):387-93. PubMed ID: 9621464
[No Abstract] [Full Text] [Related]
9. MHC restriction: slip-sliding away.
Wilson IA; Stanfield RL
Nat Immunol; 2005 May; 6(5):434-5. PubMed ID: 15843798
[No Abstract] [Full Text] [Related]
10. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses.
Grimbaldeston MA; Metz M; Yu M; Tsai M; Galli SJ
Curr Opin Immunol; 2006 Dec; 18(6):751-60. PubMed ID: 17011762
[TBL] [Abstract][Full Text] [Related]
11. Mast cell-derived proteases control allergic inflammation through cleavage of IgE.
Rauter I; Krauth MT; Westritschnig K; Horak F; Flicker S; Gieras A; Repa A; Balic N; Spitzauer S; Huss-Marp J; Brockow K; Darsow U; Behrendt H; Ring J; Kricek F; Valent P; Valenta R
J Allergy Clin Immunol; 2008 Jan; 121(1):197-202. PubMed ID: 17904627
[TBL] [Abstract][Full Text] [Related]
12. The rat mast cell degranulation test in allergy: review on principles and clinical application.
Lo C; Yokoyama MM
Hawaii Med J; 1974 Mar; 33(3):96-100. PubMed ID: 4132860
[No Abstract] [Full Text] [Related]
13. B cells, IgE and mechanisms of type I hypersensitivity in eosinophilic oesophagitis.
Mulder DJ; Justinich CJ
Gut; 2010 Jan; 59(1):6-7. PubMed ID: 20007954
[No Abstract] [Full Text] [Related]
14. [Diagnosis of suspected IgE-mediated allergy].
Bødtger U; Hoffmann HJ; Skov PS
Ugeskr Laeger; 2005 Feb; 167(6):617-9. PubMed ID: 15771372
[No Abstract] [Full Text] [Related]
15. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE on mast cells.
Bryce PJ; Miller ML; Miyajima I; Tsai M; Galli SJ; Oettgen HC
Novartis Found Symp; 2005; 271():15-24; discussion 24-38, 95-9. PubMed ID: 16605126
[TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting cells in allergy.
von Bubnoff D; Geiger E; Bieber T
J Allergy Clin Immunol; 2001 Sep; 108(3):329-39. PubMed ID: 11544450
[TBL] [Abstract][Full Text] [Related]
17. IgE-mediated antigen presentation.
Mudde GC; Bheekha R; Bruijnzeel-Koomen CA
Allergy; 1995 Mar; 50(3):193-9. PubMed ID: 7677234
[No Abstract] [Full Text] [Related]
18. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
Masuda A; Nakamura A; Maeda T; Sakamoto Y; Takai T
J Exp Med; 2007 Apr; 204(4):907-20. PubMed ID: 17420263
[TBL] [Abstract][Full Text] [Related]
19. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.
Mukai K; Matsuoka K; Taya C; Suzuki H; Yokozeki H; Nishioka K; Hirokawa K; Etori M; Yamashita M; Kubota T; Minegishi Y; Yonekawa H; Karasuyama H
Immunity; 2005 Aug; 23(2):191-202. PubMed ID: 16111637
[TBL] [Abstract][Full Text] [Related]
20. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?
Ott VL; Cambier JC
J Allergy Clin Immunol; 2000 Sep; 106(3):429-40. PubMed ID: 10984360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
